Pharmacokinetics, bioavailability and plasma protein binding of tolfenamic acid in rainbow trout (Oncorhynchus mykiss)

被引:1
|
作者
Corum, Orhan [1 ]
Corum, Duygu Durna [1 ]
Marin, Pedro [2 ]
Acar, Omer Faruk [3 ]
Aksoy, Mert [3 ]
Uney, Kamil [4 ]
机构
[1] Univ Hatay Mustafa Kemal, Fac Vet Med, Dept Pharmacol & Toxicol, TR-31060 Hatay, Turkiye
[2] Univ Murcia, Fac Vet Med, Dept Pharmacol, Murcia, Spain
[3] Univ Kastamonu, Fac Vet Med, Kastamonu, Turkiye
[4] Selcuk Univ, Fac Vet Med, Dept Pharmacol & Toxicol, Konya, Turkiye
关键词
bioavailability; pharmacokinetics; plasma protein binding; rainbow trout; tolfenamic acid; PHARMACODYNAMICS; FISH; MARBOFLOXACIN; DISPOSITION; EXCRETION; DOGS;
D O I
10.1002/vms3.1533
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Although research on the mechanism and control of pain and inflammation in fish has increased in recent years, the use of analgesic drugs is limited due to the lack of pharmacological information about analgesic drugs. Tolfenamic acid is a nonsteroidal anti-inflammatory drug and can be used in fish due to its low side effect profile and superior pharmacokinetic properties. Objectives: The pharmacokinetics, bioavailability and plasma protein binding of tolfenamic acidwere investigated following single intravascular (IV), intramuscular (IM) and oral administration of 2 mg/kg in rainbow trout at 13 +/- 0.5 degrees C. Methods: The experiment was carried out on a total of 234 rainbow trout (Oncorhynchus mykiss). Tolfenamic acid was administered to fish via IV, IM and oral route at a dose of 2 mg/kg. Blood samples were taken at 13 different sampling times until the 72 h after drug administration. The plasma concentrations of tolfenamic acid were quantified using high pressure liquid chromatography-ultraviolet (UV) and pharmacokinetic parameters were assessed using non-compartmental analysis. Results: The elimination half-life (t1/2 lambda z) of tolfenamic acid for IV, IM and oral routes was 3.47, 6.75 and 9.19 h, respectively. For the IV route, the volume of distribution at a steady state and total body clearance of tolfenamic acid were 0.09 L/kg and 0.03 L/h/kg, respectively. The peak plasma concentration and bioavailability for IM and oral administration were 8.82 and 1.24 mu g/mL, and 78.45% and 21.48%, respectively. Themean plasma protein binding ratio of tolfenamic acid in rainbow trout was 99.48% and was not concentration dependent. Conclusions: While IM route, which exhibits both the high plasma concentration and bioavailability, can be used in rainbow trout, oral route is not recommended due to low plasma concentration and bioavailability. However, there is a need to demonstrate the pharmacodynamic activity of tolfenamic acid in rainbow trout.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Pharmacokinetics and Plasma Protein Binding of Flunixin in Rainbow Trout (Oncorhynchus mykiss)
    Uney, Kamil
    Corum, Orhan
    Corum, Duygu Durna
    Coskun, Devran
    Sakin, Fatih
    Elmas, Muammer
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2025, 48 (02) : 103 - 109
  • [2] PHARMACOKINETICS, BIOAVAILABILITY, PLASMA-PROTEIN BINDING AND DISPOSITION OF NALIDIXIC-ACID IN RAINBOW-TROUT (ONCORHYNCHUS-MYKISS)
    JARBOE, H
    TOTH, BR
    SHOEMAKER, KE
    GREENLEES, KJ
    KLEINOW, KM
    XENOBIOTICA, 1993, 23 (09) : 961 - 972
  • [3] Pharmacokinetics and Bioavailability of Carprofen in Rainbow Trout (Oncorhynchus mykiss) Broodstock
    Uney, Kamil
    Corum, Duygu Durna
    Terzi, Ertugrul
    Corum, Orhan
    PHARMACEUTICS, 2021, 13 (07)
  • [4] COMPARATIVE PHARMACOKINETICS AND BIOAVAILABILITY OF OXOLINIC ACID AND OXYTETRACYCLINE IN RAINBOW-TROUT (ONCORHYNCHUS-MYKISS)
    BJORKLUND, HV
    BYLUND, G
    XENOBIOTICA, 1991, 21 (11) : 1511 - 1520
  • [5] Plasma pharmacokinetics of melamine and a blend of melamine and cyanuric acid in rainbow trout (Oncorhynchus mykiss)
    Xue, Min
    Qin, Yuchang
    Wang, Jia
    Qiu, Jing
    Wu, Xiufeng
    Zheng, Yinhua
    Wang, Qiuyan
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2011, 61 (01) : 93 - 97
  • [6] Pharmacokinetics of eugenol in rainbow trout (Oncorhynchus mykiss)
    Guenette, S. A.
    Uhland, F. C.
    Helie, P.
    Beaudry, F.
    Vachon, P.
    AQUACULTURE, 2007, 266 (1-4) : 262 - 265
  • [7] Plasma amino acid levels in rainbow trout (Oncorhynchus mykiss)
    Schuhmacher, A
    Schon, J
    Goldberg, M
    Gropp, JM
    JOURNAL OF APPLIED ICHTHYOLOGY, 1995, 11 (3-4) : 309 - 316
  • [8] PHARMACOKINETICS, BIOAVAILABILITY, DISTRIBUTION, AND METABOLISM OF SULFADIMETHOXINE IN THE RAINBOW-TROUT (ONCORHYNCHUS-MYKISS)
    KLEINOW, KM
    BEILFUSS, WL
    JARBOE, HH
    DROY, BF
    LECH, JJ
    CANADIAN JOURNAL OF FISHERIES AND AQUATIC SCIENCES, 1992, 49 (05) : 1070 - 1077
  • [9] INFLUENCE OF ORMETOPRIM ON THE BIOAVAILABILITY, DISTRIBUTION, AND PHARMACOKINETICS OF SULFADIMETHOXINE IN RAINBOW-TROUT (ONCORHYNCHUS-MYKISS)
    DROY, BF
    TATE, T
    LECH, JJ
    KLEINOW, KM
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1989, 94 (01): : 303 - 307
  • [10] Methyltestosterone pharmacolinetics and oral bioavailability in rainbow trout (Oncorhynchus mykiss)
    Vick, AM
    Hayton, WL
    AQUATIC TOXICOLOGY, 2001, 52 (3-4) : 177 - 188